Sign inJoin waitlistJoin the waitlist

JH

Julio Hajdenberg

Physician · Lahey Clinic

Credentials: · · · · · · · ·

History

Lahey Clinic
2026–Present

Hematology and Medical Oncology
Internal Medicine

Research

Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase…
Cancer · 2003 · 307 citations
Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America
Cancer · 2010 · 203 citations
Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma
Journal of Clinical Oncology · 2017 · 145 citations

AH
Adrienne Hery
2 papers
AC
Alan Cartmell
2 papers
Brendan Curti
2 papers
CH
Charles Henderson
2 papers
Charles Rosser
2 papers
CR
Christopher Ryan
2 papers
David McDermott
2 papers
HD
Harry Drabkin
2 papers
JH
John Hainsworth
2 papers
JB
Jonathan Beilan
2 papers · 2 as a resident
LC
Lisa Cupit
2 papers
Luis Chu
2 papers

Clinical trials

Safety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed AML
Principal investigator · Completed · Phase 2
Chroma Therapeutics
2009–2011
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2022–2028